Cargando…

A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients

BACKGROUND/OBJECTIVES: Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients. An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms. We investigated whether obesity is associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kooistra, Emma J., de Nooijer, Aline H., Claassen, Wout J., Grondman, Inge, Janssen, Nico A. F., Netea, Mihai G., van de Veerdonk, Frank L., van der Hoeven, Johannes G., Kox, Matthijs, Pickkers, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829495/
https://www.ncbi.nlm.nih.gov/pubmed/33495522
http://dx.doi.org/10.1038/s41366-021-00747-z
_version_ 1783641179314716672
author Kooistra, Emma J.
de Nooijer, Aline H.
Claassen, Wout J.
Grondman, Inge
Janssen, Nico A. F.
Netea, Mihai G.
van de Veerdonk, Frank L.
van der Hoeven, Johannes G.
Kox, Matthijs
Pickkers, Peter
author_facet Kooistra, Emma J.
de Nooijer, Aline H.
Claassen, Wout J.
Grondman, Inge
Janssen, Nico A. F.
Netea, Mihai G.
van de Veerdonk, Frank L.
van der Hoeven, Johannes G.
Kox, Matthijs
Pickkers, Peter
author_sort Kooistra, Emma J.
collection PubMed
description BACKGROUND/OBJECTIVES: Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients. An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms. We investigated whether obesity is associated with differences in inflammatory, respiratory, and clinical outcome parameters in critically ill COVID-19 patients. SUBJECTS/METHODS: Sixty-seven COVID-19 ICU patients were divided into obese (BMI ≥ 30 kg/m(2), n = 18, 72% class I obesity, 28% class II obesity) and non-obese (BMI < 30 kg/m(2), n = 49) groups. Concentrations of circulating interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interferon gamma-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, and IL-1 receptor antagonist (RA) were determined from ICU admission until 10 days afterward, and routine laboratory and clinical parameters were collected. RESULTS: BMI was 32.6 [31.2–34.5] and 26.0 [24.4–27.7] kg/m(2) in the obese and non-obese group, respectively. Apart from temperature, which was significantly lower in obese patients (38.1 [36.9–38.9] vs. 38.7 [38.0 −39.5] °C, p = 0.02), there were no between-group differences on ICU admission. Plasma cytokine concentrations declined over time (p < 0.05 for all), but no differences between obese and non-obese patients were observed. Also, BMI did not correlate with the cytokine response (IL-6 r = 0.09, p = 0.61, TNF-α r = 0.03, p = 0.99, IP-10 r = 0.28, p = 0.11). The kinetics of clinical inflammatory parameters and respiratory mechanics were also similar in both groups. Finally, no differences in time on ventilator, ICU length of stay or 40-day mortality between obese and non-obese patients were apparent. CONCLUSIONS: In COVID-19 patients requiring mechanical ventilation in the ICU, a higher BMI is not related to a different immunological response, unfavorable respiratory mechanics, or impaired outcome.
format Online
Article
Text
id pubmed-7829495
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78294952021-01-25 A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients Kooistra, Emma J. de Nooijer, Aline H. Claassen, Wout J. Grondman, Inge Janssen, Nico A. F. Netea, Mihai G. van de Veerdonk, Frank L. van der Hoeven, Johannes G. Kox, Matthijs Pickkers, Peter Int J Obes (Lond) Article BACKGROUND/OBJECTIVES: Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients. An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms. We investigated whether obesity is associated with differences in inflammatory, respiratory, and clinical outcome parameters in critically ill COVID-19 patients. SUBJECTS/METHODS: Sixty-seven COVID-19 ICU patients were divided into obese (BMI ≥ 30 kg/m(2), n = 18, 72% class I obesity, 28% class II obesity) and non-obese (BMI < 30 kg/m(2), n = 49) groups. Concentrations of circulating interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interferon gamma-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, and IL-1 receptor antagonist (RA) were determined from ICU admission until 10 days afterward, and routine laboratory and clinical parameters were collected. RESULTS: BMI was 32.6 [31.2–34.5] and 26.0 [24.4–27.7] kg/m(2) in the obese and non-obese group, respectively. Apart from temperature, which was significantly lower in obese patients (38.1 [36.9–38.9] vs. 38.7 [38.0 −39.5] °C, p = 0.02), there were no between-group differences on ICU admission. Plasma cytokine concentrations declined over time (p < 0.05 for all), but no differences between obese and non-obese patients were observed. Also, BMI did not correlate with the cytokine response (IL-6 r = 0.09, p = 0.61, TNF-α r = 0.03, p = 0.99, IP-10 r = 0.28, p = 0.11). The kinetics of clinical inflammatory parameters and respiratory mechanics were also similar in both groups. Finally, no differences in time on ventilator, ICU length of stay or 40-day mortality between obese and non-obese patients were apparent. CONCLUSIONS: In COVID-19 patients requiring mechanical ventilation in the ICU, a higher BMI is not related to a different immunological response, unfavorable respiratory mechanics, or impaired outcome. Nature Publishing Group UK 2021-01-25 2021 /pmc/articles/PMC7829495/ /pubmed/33495522 http://dx.doi.org/10.1038/s41366-021-00747-z Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Kooistra, Emma J.
de Nooijer, Aline H.
Claassen, Wout J.
Grondman, Inge
Janssen, Nico A. F.
Netea, Mihai G.
van de Veerdonk, Frank L.
van der Hoeven, Johannes G.
Kox, Matthijs
Pickkers, Peter
A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
title A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
title_full A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
title_fullStr A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
title_full_unstemmed A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
title_short A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
title_sort higher bmi is not associated with a different immune response and disease course in critically ill covid-19 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829495/
https://www.ncbi.nlm.nih.gov/pubmed/33495522
http://dx.doi.org/10.1038/s41366-021-00747-z
work_keys_str_mv AT kooistraemmaj ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT denooijeralineh ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT claassenwoutj ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT grondmaninge ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT janssennicoaf ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT neteamihaig ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT vandeveerdonkfrankl ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT vanderhoevenjohannesg ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT koxmatthijs ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT pickkerspeter ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT kooistraemmaj higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT denooijeralineh higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT claassenwoutj higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT grondmaninge higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT janssennicoaf higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT neteamihaig higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT vandeveerdonkfrankl higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT vanderhoevenjohannesg higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT koxmatthijs higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT pickkerspeter higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients
AT higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients